Pembrolizumab for treating locally advanced or metastatic urothelial carcinoma after platinum-containing chemotherapy

  • Technology appraisal guidance
  • TA692
  • Published: 

Evidence

Documents containing the evidence that was used to develop the recommendations.

Supporting evidence